Mp25-19 results of the pcm-204 phase 2b trial of partial-gland ablation for men with intermediate-risk prostate cancer with padeliporfin (wst11 or tookad) vascular-targeted photodynamic therapy
Journal of Urology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要